Boston Scientific

Boston Scientific (BSX) is a publicly traded company in the Health Care sector, specifically within the Health Care Equipment industry. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

The company reports trailing twelve-month revenue of $2.22B and net income of $190.00M.

Key metrics include a return on equity of 0.7%.

Investors tracking BSX can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.